Biomatrix
Biomatrix has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Mar 12, 2026: “ECM proteins regulate microRNA-mediated direct reprogramming of fibroblasts into cardiomyocytes via YAP signaling”.
1 paper studies it3 findingsUpdated
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: European Commission and 2 more
- 3 of 3 findings with company ties
- Cells1
What did studies of biomatrix find?
3Studies of biomatrix measured 3 outcomes: hippo–YAP signaling, TNNT2 and cTnT+ cells.
Hippo–YAP signaling
downin human cells1
1 study
Hippo–YAP signaling
downin human cells1
Biomatrix inhibits hippo–YAP signaling in human cells (at 3 days post-seeding).
“laminin and biomatrix reduced YAP activation, favoring cardiac transdifferentiation over proliferation.”
Cellsat 3 days post-seedingadult human cardiac fibroblasts3 days
Frontiers in bioengineering and biotechnology
TNNT2
upin human cells1
1 study
TNNT2
upin human cells1
Biomatrix increases TNNT2 in human cells (cultured on biomatrix).
“Gene expression analyses demonstrated marked upregulation of cardiac markers TNNT2, ACTC1, and CACNA1C in biomatrix-cultured cells.”
Cellscultured on biomatrixadult human cardiac fibroblasts
Frontiers in bioengineering and biotechnology
cTnT+ cells
upin human cells1+20%
1 study
cTnT+ cells
upin human cells1+20%
Biomatrix increases cTnT+ cells in human cells (cultured on biomatrix vs other substrates) (approximately 20%).
“Biomatrix significantly enhanced reprogramming efficiency, yielding approximately 20% cardiac Troponin T (cTnT)+ cells compared to other substrates.”
Cellscultured on biomatrix vs other substratesadult human cardiac fibroblasts
Frontiers in bioengineering and biotechnology